15th week of 2011 patent applcation highlights part 33 |
Patent application number | Title | Published |
20110087001 | POLYMERS OF ETHYLENE OXIDE AND CARBON DIOXIDE - The present disclosure is directed, in part, to methods of synthesizing a poly(ethylene carbonate) polymer from the reaction of ethylene oxide (EO) and carbon dioxide (CO | 2011-04-14 |
20110087002 | Methods for Cyclizing Synthetic Polymers - The invention provides methods and compositions for production of a cyclic polymer in a cell free system. In general, the methods of the invention involve ligating first and second recombinant intein domains to a linear synthetic polymer to form a compound containing the structure: D | 2011-04-14 |
20110087003 | GLYCOPEPTIDE COMPOSITIONS - The invention include glycopeptides having a glycoside and a peptide covalently bound through an amide bond. The glycopeptides may also include a diagnostic or therapeutic agent bound to the glycopeptide. A metal, such as a radionuclide, may also be chelated to the glycopeptide. Specific embodiments of the invention relate to glycopeptides made of chitosan covalently bound to a poly(amino acid) such as poly(glutamic acid) or poly(aspartic acid). Diagnostic agents conjugated to the glycopeptide may facilitate imaging. Specific therapeutic agents that may be conjugated to the glycopeptide include anticancer drugs, rheumatoid arthritis drugs, anticoagulants, anti-angiogenesis drugs, apoptosis drugs, osteoporosis drugs, steroids, and anti-inflammatory drugs. Some agents, such as radionuclides, may have both diagnostic and therapeutic effects. The glycopeptides may be made by combining a glycoside and a peptide in the presence of a carbodiimide and an acid group activator to form an amide bond between the glycoside and the peptide. | 2011-04-14 |
20110087004 | ENHANCED ORAL TRANSCOMPARTMENTAL DELIVERY OF THERAPEUTIC OR DIAGNOSTIC AGENTS - The invention is directed to pharmaceutical compositions and methods for delivery of a therapeutic or diagnostic agent from one bodily compartment to one or more other bodily compartment by administering one of the following conjugates: a polymer having multiple functional groups at least one of which is covalently bound to a therapeutic or diagnostic agent, and at least one cell uptake promoter covalently bound to the therapeutic or diagnostic agent; or a polymer and at least one cell uptake promoter bound thereto; the polymer further comprising multiple functional groups at least one of which is covalently bound a therapeutic or diagnostic agent. | 2011-04-14 |
20110087005 | HLA-BINDING PEPTIDE, PRECURSOR THEREOF, AND DNA FRAGMENT AND RECOMBINANT VECTOR CODING FOR SAID HLA-BINDING PEPTIDE - An HLA-binding peptide binding to an HLA-A type molecule is provided that includes one or more types of amino acid sequence selected from the group consisting of SEQ ID NOS: 1 to 52, and not less than 8 and not more than 11 amino acid residues. All of these amino acid sequences are amino acid sequences predicted to bind to a human HLA-A molecule using a prediction program employing an active learning experiment method shown in FIG. | 2011-04-14 |
20110087006 | DNA Sequence Encoding a Retinoic Acid Regulated Protein - The present invention concerns a novel retinoic acid regulated gene whose expression product displays useful morphogenic/mitogenic properties. The present invention further concerns an isolated nucleic acid of SEQ ID NO:1 encoding a retinoic acid regulated expression product having an amino acid sequence of SEQ ID NO:2. | 2011-04-14 |
20110087007 | Cytokine-Like Proteins - A full-length cDNA corresponding to an EST (AA418955), which does not show any homology to other proteins in the database but has a weak homology to G-CSF, has been successfully isolated by synthesizing primers based on the EST sequence, and effecting PCR-cloning from a human fetal spleen library. Sequencing of the thus-isolated cDNA and analysis of its structure revealed that the cDNA has typical characteristics of a factor belonging to the IL-6/G-CSF/MGF family. It is also found out that the culture supernatant of said sequence-transfected CHO cells shows a proliferation supporting activity towards bone marrow cells in the coexistence of kit ligand. | 2011-04-14 |
20110087008 | METHODS FOR PURIFICATION OF ALPHA-1-ANTITRYPSIN ANDAPOLIPOPROTEIN A-1 - This invention relates to protein separation and purification methods for both alpha-1-antitrypsin (AAT, also known as alpha-1 proteinase inhibitor, API, and A | 2011-04-14 |
20110087009 | PROCESS FOR THE CONTROLLED PRODUCTION OF ORGANIC PARTICLES - A process for the production of a microparticle or a nanoparticle of a chemical compound comprising the steps of providing a solution of said chemical compound in a first liquid; providing a second liquid in which said chemical compound is insoluble or substantially insoluble; combining said liquids in a region of high shear thereby causing formation of said particles; and isolating said particles of said compound. The processing time of a coacervation style process can be reduced and the yield can be substantially increased both by control of the precipitation step which allows for desolvation step to be dispensed with leading to significant process time reduction. The invention also provides a molecular mixing unit comprising an outer body defining a mixing zone; a shear means to provide shear liquid in said mixing zone; at least one fluid inlet means for a first liquid; at least one fluid inlet means for a second liquid and a fluid outlet means. | 2011-04-14 |
20110087010 | ANTI-ANGIOGENIC COMPOUNDS - The present invention provides AA targeting compounds which comprise AA targeting agent-linker conjugates which are linked to a combining site of an antibody. Various uses of the compounds are provided, including methods to treat disorders connected to abnormal angiogenesis. | 2011-04-14 |
20110087011 | SEPARATION OF REBAUDIOSIDE A FROM STEVIA GLYCOSIDES USING CHROMATOGRAPHY - Disclosed are methods for the chromatographic separation of rebaudioside A from stevioside in glycoside solutions that are derived from stevia. The chromatographic separation may be an adsorb/desorb type of chromatographic separation or a fractionation type of chromatographic separation. | 2011-04-14 |
20110087012 | NUCLEIC ACID MOLECULES CODING FOR A PROTEIN WITH DEACETYLASE ACTIVITY, SAID PROTEIN, AND METHOD FOR THE PRODUCTION OF CHITOSAN - The invention relates to nucleic acid molecules selected from the group comprising: a) nucleic acid molecules that code for a form of the polypeptide with the derived amino acid sequence according to SEQ ID No. 3, said polypeptide having a deacetylase activity; b) nucleic acid molecules that comprise the nucleotide sequence according to SEQ ID No. 1 or SEQ ID No. 2 and that code for one form of said polypeptide; c) nucleic acid molecules that code for a fragment or a derivative of a polypeptide that is coded by a nucleic acid molecule according to a) or b), wherein one or more amino acid groups are conservatively substituted in said derivative as compared to said polypeptide, and wherein said fragment or derivative has a deacetylase activity; d) nucleic acid molecules that have a sequence identity of at least 95% with a nucleic acid molecule according to a) to c), and that code for a polypeptide with deacetylase activity; e) nucleic acid molecules that have a sequence identity of at least 70% with a nucleic acid molecule according to a) to c) and that code for a polypeptide with deacetylase activity; f) or the complementary string of a nucleic acid molecule according to a) to e). | 2011-04-14 |
20110087013 | Friedel-Crafts acylation for the synthesis of aryl- and heteroaryl-(3-ethyl-4-nitrophenyl)-methanones - The present invention concerns a synthesis process comprising the following steps (i) reacting 3-ethyl-4-nitrobenzoic acid with thionyl chloride to produce a 3-ethyl-4-nitrobenzoic acid chloride or a 3-ethyl-4-nitrobenzoic acid anhydride from 3-ethyl-4-nitrobenzoic acid by means of water cleavage and (ii) Friedel-Crafts acylation by reacting the 3-ethyl-4-nitrobenzoic acid chloride or the 3-ethyl-4-nitrobenzoic acid anhydride with an optionally substituted aryl-H to form an optionally substituted (3-ethyl-4-nitrophenyl)-aryl-methanone. In addition the present invention concerns compounds containing (3-ethyl-4-nitrophenyl)-aryl-methanone, characterized in that the optionally substituted aryl is an optionally substituted condensed aromate. | 2011-04-14 |
20110087014 | Process for the manufacture of oligonucleotides - A process for manufacturing an oligonucleotide which comprises removing β-eliminating phosphorus-protecting groups, in particular β-cyanoethyl protective groups from a protected oligonucleotide, wherein said removing comprises contacting the protected oligonucleotide with an amine solution in a solvent which preferably does not consist of pyridine, wherein the conjugate acid of the amine has preferably a pKa of greater than 11.5, and wherein the concentration of the amine in the solution is less than 0.5 mole/liters. | 2011-04-14 |
20110087015 | Nucleoside and nucleotide having an unnatural base and use thereof - The object of the present invention is to provide a nucleoside or a nucleotide, or a derivative thereof, which has an unnatural base. The nucleoside and others of the present invention are characterized by having a 2-amino-6-(2-thiazolyl)purin-9-yl group or a 2-amino-6-(2-oxazolyl)purin-9-yl group as a base, wherein the 4- and/or 5-position of the thiazolyl or oxazolyl group may be substituted. | 2011-04-14 |
20110087016 | System and Method for Emulsion Breaking and Recovery of Biological Elements - An embodiment of a method for extracting biological material from an emulsion is described that comprises the steps of a) breaking an emulsion comprising a plurality of aqueous droplets in a continuous phase of an oil using a solvent to produce a combined aqueous-oil mixture, where the solvent disrupts the aqueous droplets which release a plurality of biological elements each immobilized on a substrate into the combined aqueous-oil mixture; b) introducing an inorganic salt to the combined aqueous-oil mixture causing a phase separation of the mixture into a first phase comprising an aqueous solution and the biological elements and a second phase comprising the solvent and the oil; c) extracting the first phase from the second phase; and d) collecting the substrate immobilized biological elements from the first phase. | 2011-04-14 |
20110087017 | PROCESS FOR THE PREPARATION OF COMPOUNDS USEFUL AS INHIBITORS OF SGLT2 - The present invention is directed to a novel process for the preparation of compounds having inhibitory activity against sodium-dependent glucose transporter (SGLT) being present in the intestine or kidney. | 2011-04-14 |
20110087018 | Low Temperature, Single Solvent Process for the Production of Sucrose-6-Ester - A method for the preparation of a sucrose-6-ester is disclosed. In a first step of the method, sucrose in a polar aprotic solvent is reacted with an organotin-based acylation promoter. The water of reaction is removed at a temperature that does not exceed about 80° C. In one aspect, the water is removed by distillation of part of the polar aprotic solvent at reduced pressure. In a second step, a carboxylic acid anhydride is added. In one aspect, the resulting reaction mixture is maintained at a temperature of 10° C. or less for a period of time sufficient to produce a sucrose-6-ester. The sucrose-6-ester can be converted to sucralose. | 2011-04-14 |
20110087019 | Process for the production of sucrose-6-ester - A process for the production of sucrose-6-ester is disclosed. The process includes, in order, the steps of:
| 2011-04-14 |
20110087020 | PROCESS FOR MAKING ORGANIC PHOTOSENSITIVE PIGMENT - Processes for making photosensitive organic pigments for use in imaging members, specifically processes for making a photosensitive phthalocyanine pigments having a specific crystal form, comprising dissolving the pigment in a mixture of a haloacetic acid and alkylene halide to form a solution, precipitating the pigment by adding the solution to a non-solvent system, the solution comprised of one or more organic solvents and a small amount of water, wherein the amount of water controls the crystal form of the pigment, followed by a treatment with a halobenzene to obtain a highly photosensitive second crystal form of the pigment. | 2011-04-14 |
20110087021 | NOVEL PREPARATION PROCESS - A process for preparing compounds of the formula (I) | 2011-04-14 |
20110087022 | Dipeptidyl Peptidase Inhibitors - Compounds, pharmaceuticals, kits and methods are provided for use with DPP-IV and other S9 proteases that comprise a member selected from the group consisting of: | 2011-04-14 |
20110087023 | METHOD FOR PRODUCING 2,4,6-TRIS(HYDROXYPHENYL)-1,3,5-TRIAZINE COMPOUND - The present invention provides a method of producing 2,4,6-tris(hydroxyphenyl)-1,3,5-triazine compound in which no rapid solidification or the like occurs and generation of by-products is suppressed, thereby enabling to reduce decrease in the yield. | 2011-04-14 |
20110087024 | PROCESS FOR THE PREPARATION OF PALIPERIDONE INTERMEDIATES - The present invention relates to a process for the preparation of 3-(2-chloroethyl)-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrrido[1,2-a]-pyrimidin-4-one; and its use in the synthesis of paliperidone. | 2011-04-14 |
20110087025 | METHOD FOR PRODUCING 3-AMIDINOPHENYLALANINE DERIVATIVES - The present invention describes a method for the synthesis of enantiomerically pure 3-amidinophenylalanine derivatives, which are used as pharmaceutically effective urokinase inhibitors, by starting from 3-cyanophenylalanine derivatives. The methods of manufacture comprising only one synthesis step lead to new intermediates, namely 3-hydroxyamidino- and 3-amidrazonophenylalanine derivatives. These intermediates or their acetyl derivatives can be reduced into the desired 3-amidino-phenylalanine derivatives under gentle conditions (H | 2011-04-14 |
20110087026 | NOVEL TRANSITION METAL COMPLEXES AND USE THEREOF IN ORGANIC LIGHT-EMITTING DIODES V - Metal complexes comprising at least one polycyclic aromatic ligand and bearing at least one deuterium atom, an organic light-emitting diode comprising at least one inventive metal complex, a light-emitting layer comprising at least one inventive metal complex, an organic light-emitting diode comprising at least one inventive light-emitting layer, the use of the at least one inventive metal complex in organic light-emitting diodes, and a device selected from the group consisting of stationary visual display units such as visual display units of computers, televisions, visual display units in printers, kitchen appliances and advertising panels, illuminations, information panels and mobile visual display units such as visual display units in cellphones, laptops, digital cameras, vehicles, and destination displays on buses and trains, comprising at least one inventive organic light-emitting diode. | 2011-04-14 |
20110087027 | SYNTHETIC METHODS FOR SPIRO-OXINDOLE COMPOUNDS - This invention is directed to methods of preparing certain spiro-oxindole derivatives, which are useful for the treatment and/or prevention of sodium channel-mediated diseases or conditions, such as pain. | 2011-04-14 |
20110087028 | METHOD FOR PREPARING CLOPIDOGREL AND ITS DERIVATIVES - The present invention relates to a method for preparing Clopidogrel and its derivatives. More particularly, the present invention is a method for preparation of (S)-2-Clopidogrel and its derivatives, which are active inhibitors of platelet aggregation, from an optically active (S)-2-chlorophenyl glycine alkyl ester through hydrolysis of racemic 2-chlorophenylglycine alkyl esters using an enzyme. The present invention employs a simple procedure to prepare Clopidogrel and its derivatives. Because no chiral resolving agents are used except for a small amount of enzyme, the cost of preparation can be reduced. In addition, the present invention is suitable for synthesizing highly optical-active Clopidogrel and its derivatives on a large scale by using optically active (S)-2-chlorophenylglycine alkyl ester obtained in high yield as an intermediate, and is also environmentally friendly since no highly toxic reagents are employed. | 2011-04-14 |
20110087029 | Process for Preparing Pyridyl-Substituted Pyrazoles - The present invention relates to a process for preparing 1-pyridyl-substituted pyrazoles, comprising the reaction of acetyleneketones with pyridylhydrazine derivatives to give 1-pyridyl-substituted dihydro-1H-pyrazoles, the further reaction thereof with elimination of water to give 1-pyridyl-substituted trihalomethylpyrazoles, and the further processing thereof. | 2011-04-14 |
20110087030 | Process for the manufacture of enantiomerically pure antifungal azoles as ravuconazole and isavuconazole - A new technical process for preparation of enantiomerically pure antifungal compounds of formula I by resolution of the racemates has been disclosed. | 2011-04-14 |
20110087031 | 1,3-Diiodohydantoin compound and production method thereof - The present invention provides a means which can inhibit release of I | 2011-04-14 |
20110087032 | PREPARATION OF SATURATED IMIDAZOLINIUM SALTS AND RELATED COMPOUNDS - Methods for the preparation of saturated imidazolinium salts and related compounds that comprises reaction of formamidines with compounds such as dihaloethane and an optional base are disclosed. Alternatively, the imidazolinium salts and related compounds can be prepared in a one-step process without purification of the formamidine reactant. These methods make it possible to obtain numerous imidazolinium salts and related compounds under solvent-free reaction conditions and in excellent yields. | 2011-04-14 |
20110087033 | Processes for the Preparation of 2-(1-Phenylethyl)isoindolin-1-one Compounds - Methods for preparation of isoindolin-1-one compounds are described. | 2011-04-14 |
20110087034 | Organic Semiconductor Material - A dihydroindacene compound represented by the following formula (1): | 2011-04-14 |
20110087035 | PROCESS FOR THE PREPARATION OF DIHYDROPYRAN - The present invention relates to a process for the preparation of 2,3-dihydropyran (DHP, CAS [110-87-2]) and its use in industrial chemistry. | 2011-04-14 |
20110087036 | PROCESS FOR PREPARING DIHYDROPYRAN AND ITS USE AS PROTECTIVE AGENT - A process for the protection of a compound having at least one reactive functional group selected from hydroxy, mercapto, carboxyl, amino and amide, with 3,4-dihydro-2H-pyran (DHP), wherein said DHP is obtained by contacting tetrahydrofurfuryl alcohol (THFA) entrained in a carrier gas with a catalyst comprising aluminium oxide (Al | 2011-04-14 |
20110087037 | SYNTHESIS OF RING B ABEO-STEROLS AS NOVEL INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS - Novel 3β-hydroxy-Δ | 2011-04-14 |
20110087038 | PROCESS AND DEVICE FOR THE OXIDATION OF ORGANIC COMPOUNDS - The invention relates to a process for the oxidation of organic compounds by means of oxygen, in which, in a first step, the organic compound and at least part of the oxygen required for the oxidation are introduced into a first reaction zone which is operated isothermally and with backmixing and, in a second step, the reaction mixture from the first reaction zone is introduced into a second reaction zone which is operated adiabatically. The invention further relates to a reactor for carrying out the process, which comprises at least one isothermal reaction zone ( | 2011-04-14 |
20110087039 | IMIDE COMPLEX, METHOD FOR PRODUCING THE SAME, METAL-CONTAINING THIN FILM AND METHOD FOR PRODUCING THE SAME - Objects of the present invention are to provide a novel niobium or tantalum complex having good vapor pressure and becoming a raw material for producing a niobium- or tantalum-containing thin film by a method such as CVD method, ALD method or the like, a method for producing the same, a metal-containing thin film using the same, and a method for producing the same. The present invention relates to producing an imide complex represented by the general formula (1) by, for example, the reaction between M | 2011-04-14 |
20110087040 | Esters with Antimicrobial, Bioresistant and Fungal Resistant Properties - A bromine/nitro moiety linked into the backbone of an ester or other compound over a wide range of occurrence rates provides antimicrobial, bio-resistant and fungal resistant properties for metal working fluids (MWF)s and other coatings. The moiety can be have the bromo and nitro groups linked to the same or different carbon atoms. The present invention also relates to urethanes, urea, amides, imides, carbonates, ethers, siloxanes, and many other types of linkages essential to MWF bases. | 2011-04-14 |
20110087041 | PROCESS FOR PRODUCING URETHANE (METHA)ACRYLATE - An object of the present invention is to provide a process for producing a urethane (meth)acrylate safely with good productivity, and for achieving the object, the invention provides a process for continuously producing a urethane (meth)acrylate, containing causing a mixed liquid of a compound (A) having a hydroxyl group and a (meth)acryloyl group and a compound (B) having an isocyanate group to pass continuously and densely through a tubular microchannel formed in a heat-conducting reaction device, and reacting the hydroxyl group of the compound (A) with the isocyanate group of the compound (B), in which the tubular microchannel in the reaction device has a space size making a fluid cross-sectional area, through which the mixed liquid passes densely, of from 0.1 to 4.0 mm | 2011-04-14 |
20110087042 | CRYSTALLINE OXYBUTYNIN AND PROCESS FOR PREPARING THE SAME - The present invention relates to a crystalline oxybutynin base and process for preparing the same. Further, this invention discloses a process for preparing an acid addition salt of oxybutynin employing the crystalline oxybutynin base. | 2011-04-14 |
20110087043 | Site-Specific Inhibitors of Histone Methyltransferase (HMTASE) and Process of Preparation Thereof - The present invention relates to compounds of structural formula I as site-specific inhibitors of histone methyltransferase, where R | 2011-04-14 |
20110087044 | Process for preparing polyol esters - The present invention relates to a process for preparing polyol esters by reacting polyols with linear or branched aliphatic monocarboxylic acids having 3 to 20 carbon atoms in the presence of an adsorbent and subsequent steam treatment in the course of workup of the crude ester. | 2011-04-14 |
20110087045 | Process for preparing polyol esters - The present invention relates to a process for preparing polyol esters by reacting polyols with linear or branched aliphatic monocarboxylic acids having 3 to 20 carbon atoms by partial recycling of the aliphatic monocarboxylic acid removed into the esterification reaction or into subsequent esterification batches. | 2011-04-14 |
20110087046 | Process for lightening the color of polyol esters - The present invention relates to a process for lightening the color of polyol esters by reacting polyols with linear or branched aliphatic monocarboxylic acids having 3 to 20 carbon atoms, wherein the reaction product is worked up without using adsorbents and comprises a treatment with ozone or ozone-containing gases and an immediately subsequent steam treatment with subsequent drying. | 2011-04-14 |
20110087047 | Vinyl acetate production process - A process for the production of vinyl acetate is disclosed. The process comprises reacting ethylene, acetic acid, and oxygen in the presence of a catalyst to produce a reaction mixture comprising vinyl acetate, ethylene, carbon dioxide, acetic acid and ethylene glycol diacetate. The reaction mixture is separated to a gas stream comprising ethylene, oxygen, and carbon dioxide and a crude vinyl acetate stream comprising vinyl acetate, acetic acid and ethylene glycol diacetate. An ethylene glycol diacetate stream, which comprises at least 50 wt % of ethylene glycol diacetate, is isolated from the crude vinyl acetate stream and hydrolyzed to recover acetic acid. Recovered acetic acid may be recycled to the acetoxidation reaction. | 2011-04-14 |
20110087048 | POLYMERIZABLE SULFONATE IONIC LIQUIDS AND LIQUID POLYMERS THEREFROM AND METHODS OF MAKING SAME - Disclosed is a new ionic liquid monomer salt and methods of is synthesis and polymerization. The ionic liquid monomer salt is prepared by mixing equimolar amounts of an amine, such as tris[2-(2-methoxyethoxy)-ethyl]amine and an acid functionalized polymerizable monomer, such as 2-acrylamido-2-methyl-1-propanesulfonic acid (AMPS), which is stirred at ambient temperature until salt formation is complete. Also disclosed is a new ionic liquid polymer salts and method for making the same. The synthesis of AMPS-ammonium salt polymer is accomplished by adding 2,2′-azobisisobutyronitrile (AIBN) to the ionic liquid monomer salt and heating the homogeneous melt at 70° C. for 18 hr. | 2011-04-14 |
20110087049 | METHOD OF PRODUCING PURIFIED OPTICALLY ACITVE 4-AMINO-3-(SUBSTITUTED PHENYL)BUTANOIC ACID COMPOUND - A method of producing a purified optically active 4-amino-3-(substituted phenyl)butanoic acid compound which is characterized by comprising a step of making a crude optically active 4-amino-3-(substituted phenyl)butanoic acid compound contact an organic acid in the presence of water. | 2011-04-14 |
20110087050 | ACROLEIN MANUFACTURING METHOD AND ACRYLIC ACID MANUFACTURING METHOD - The present invention relates to a method for producing acrolein, comprising step (1) of subjecting glycerol to dehydration reaction in the presence of a copper compound and a compound containing a heteroatom; step (2) of recovering acrolein generated in the dehydration reaction step (1); step (3) of recovering part or all of the copper compound which remained after the recovery of acrolein; step (4) of treating part or all of the recovered copper compound with at least one member selected from a group consisting of an oxidizing agent and acid; and step (5) of returning part or all of the copper compound treated in the above step to step (1); and a method for producing acrylic acid, comprising reacting acrolein obtained by the above method with molecular oxygen. The production method of the present invention enables efficient production of acrolein and acrylic acid from glycerol contained in plant oil and animal fats derived from carbon dioxide in air without depending on the oxidation of propylene derived from fossil resources. | 2011-04-14 |
20110087051 | Alkylene Oxide-Adducted Hydrocarbyl Amides - Provided herein are products produced by:
| 2011-04-14 |
20110087052 | Process for the manufacture of alkenones - Process for preparing an alkenone, which comprises (a) reacting a carboxylic acid halide with a vinyl ether by introducing vinyl ether into a liquid reaction medium containing carboxylic acid halide to form a halogenated precursor of the alkenone and (b) eliminating hydrogen halide from said precursor to form the alkenone. | 2011-04-14 |
20110087053 | PROCESS FOR PRODUCING ALKYLATED AROMATIC COMPOUNDS AND PROCESS FOR PRODUCING PHENOL - The invention provides an efficient process for producing alkylated aromatic compounds such as cumene in a compact reactor. The invention also provides a process for producing phenol which includes a step of producing cumene by the above process. | 2011-04-14 |
20110087054 | ISOTHERMAL MULTITUBE REACTORS AND PROCESSES INCORPORATING THE SAME - The present invention provides isothermal multitube reactors suitable for the production of chlorinated and/or fluorinated propene and higher alkenes from the reaction of chlorinated and/or fluorinated alkanes and chlorinated and/or fluorinated alkenes. The reactors utilize a feed mixture inlet temperature at least 20° C. different from a desired reaction temperature. | 2011-04-14 |
20110087055 | PROCESSES FOR THE PRODUCTION OF CHLORINATED AND/OR FLUORINATED PROPENES AND HIGHER ALKENES - The present invention provides continuous, gas phase, free radical processes for the production of chlorinated and/or fluorinated propenes or higher alkenes from the reaction of chlorinated and/or fluorinated alkanes and chlorinated and/or fluorinated alkenes, wherein wherein at least a portion of any intermediate boiler by-products generated by the process are removed from the process | 2011-04-14 |
20110087056 | ADIABATIC PLUG FLOW REACTORS AND PROCESSES INCORPORATING THE SAME - The present invention provides adiabatic plug flow reactors suitable for the production of chlorinated and/or fluorinated propene and higher alkenes from the reaction of chlorinated and/or fluorinated alkanes and chlorinated and/or fluorinated alkenes. The reactors comprise one or more designs that minimize the production of by-products at a desired conversion. | 2011-04-14 |
20110087057 | Lubricating base oil - The present invention is directed to a heavy hydrocarbon composition useful as a heavy lubricant oil base stock and to a heavy lubricant composition derived from the heavy lubricant oil base stock that remains clear and bright even after being cooled to room temperature and stored for an extended period of time. | 2011-04-14 |
20110087058 | DEOXYGENATION OF MATERIALS OF BIOLOGICAL ORIGIN - The present invention relates to a method for the deoxygenation of materials of biological origin and particularly to the removal of oxygen from biomass derived organic compounds with carbon monoxide, to yield linear and branched hydrocarbons suitable as biofuels or as blending stocks or components for biofuels, such as gas, gasoline, diesel fuel and aviation fuel, as well as solvents. The method comprises contacting a feedstock with carbon monoxide in the presence of a catalyst comprising a metal selected from a group consisting of ruthenium, manganese, rhodium, rhenium, osmium, iridium, molybdenum, copper, zinc, palladium, platinum and cobalt, in the presence of water, under alkaline conditions at a temperature from 150 to 350° C. and under a pressure from 0.1 to 150 bar, to produce hydrocarbons. | 2011-04-14 |
20110087059 | PROCESS FOR HYDROTREATMENT AND HYDROISOMERIZATION OF FEEDSTOCKS OBTAINED FROM A RENEWABLE SOURCE IMPLEMENTING A MODIFIED ZEOLITE - This invention describes a process for treatment of feedstocks obtained from a renewable source implementing a catalyst that comprises at least one hydro-dehydrogenating metal that is selected from the group that is formed by the metals of group VIB and group VIII of the periodic table and a substrate that comprises at least one zeolite that has at least one series of channels whose opening is defined by a ring with 8 oxygen atoms modified by a) at least one stage for introducing at least one alkaline cation that belongs to group IA or IIA of the periodic table, b) a stage for treating said zeolite in the presence of at least one molecular compound that contains at least one silicon atom, c) at least one stage of partial exchange of said alkaline cations by NH | 2011-04-14 |
20110087060 | SUGAR ALCOHOL SPLIT INJECTION CONVERSION - A method of hydrotreating liquefied biomass feedstock with diesel feedstock to produce alkanes is demonstrated that prevents damage to the reactor catalyst, reduces coke production, and converts nearly all of the polyols to alkanes. In order to mitigate the potential coking issue and to moderate the temperature of the catalyst bed while maintaining high conversion for sugar alcohol to hydrocarbon via a hydrotreating process, a diesel feedstock is fed over the reactor catalyst with multiple injections of polyol feedstock along the reactor. | 2011-04-14 |
20110087061 | RADIOTHERAPY APPARATUS CONTROL APPARATUS AND SPECIFIC SITE POSITION MEASURING METHOD - A specific site location measuring method according to the present invention, includes: calculating matching degrees based on a plurality of transmission images imaged by use of radiation transmitting through a specimen and a template set; selecting a template transmission image from the plurality of transmission images based on the matching degrees; adding a new template generated based on the template transmission image, to the template set; imaging a location measurement transmission image by use of radiation transmitting through the specimen; selecting an optimal template that is the most similar to a portion of the location measurement transmission image, from the template set by performing pattern matching of each of templates of the template set with the location measurement transmission image; and calculating a specific site location based on the location measurement transmission image and the optimal template. At this time, the transmission image of the specimen has a high probability that it is similar to any template of the thus-generated templates. Therefore, in the specific site location measuring method, the specific site can be measured with higher precision. | 2011-04-14 |
20110087062 | MINIATURE X-RAY TUBE FOR A CATHETER - A miniature X-ray tube for intravascular or intracorporeal radiation treatment in living beings is proposed. The X-ray tube comprises a cylindrical housing section with a longitudinal axis. The miniature X-ray tube also comprises a cylindrical or cylindrical-tube-shaped first field emission cathode arranged concentrically about the longitudinal axis in the housing with a plurality of carbon nanotubes which emit electrons radially outward. The miniature X-ray tube also comprises a second field emission cathode in the housing with a plurality of carbon nanotubes which emit electrons in the direction of longitudinal axis. The miniature X-ray tube only emits little heat and is robust against mechanical stresses. | 2011-04-14 |
20110087063 | TWO PIECE ENDOVASCULAR ANASTOMOTIC CONNECTOR - An anastomotic connector comprising an endovascular component including a vascular conduit and a supply conduit and a cannula component. The vascular conduit has first and second ends that are configured to reside within a vascular structure. The supply conduit has proximal and distal ends, where the distal end fluidicly connects to the vascular conduit between the first and second ends. The cannula component, which also includes proximal and distal ends, is received by the supply conduit. | 2011-04-14 |
20110087064 | Transferring and holding device for high-risk neonatal intensive care unit (NICU) patients - A transferring and holding device and method for holding infants having lifelines, such as IV tubes, monitor wire leads, and ventilator tubes, connected thereto. In one embodiment, the device includes a support surface adapted to hold an infant; a boundary attached to and bolstering the support surface; and at least one securing mechanism adapted to secure the lifelines and to impede the lifelines from being disconnected from the infant. The support surface preferably has openings to enable skin-to-skin contact between the infant and a person holding the infant, and at least a portion of the support surface can be a nonabsorbent, open-weave webbed material. The boundary may include a foam member, and/or a flexible plastic or metal member to provide structural support. | 2011-04-14 |
20110087065 | Artificial Insemination Device - An artificial insemination device includes a catheter, a widening tip connected to one end of the catheter for being introduced into the genital system of a female animal, and a check valve connected between the catheter and the widening tip and having a stopper supported on a spring between a first stop wall and a second stop wall for controlling the passage in the second stop wall for allowing the injected semen to pass out of the semen outlet in the first stop wall and prohibiting the injected semen from flowing backwards | 2011-04-14 |
20110087066 | DEVICES AND METHODS FOR DELIVERING AN ENDOCARDIAL DEVICE - Described herein are systems for partitioning a ventricle of a heart. The systems may include a partitioning device or implant, and an applicator for inserting, repositioning and/or removing the partitioning device. The implant may support the ventricle wall and may reduce the volume of the ventricle. In particular, described herein are systems for delivering and deploying a partitioning device into a ventricle. The delivery system may include a catheter having a distal coupling element for coupling to a partitioning device in a collapsed configuration; the catheter may also have an expansion member for applying force to the partitioning device to fully expand it into a deployed configuration and to secure or seal it against the ventricle wall. | 2011-04-14 |
20110087067 | INTERNAL RETRACTOR SYSTEMS - A retractor system is provided having an anchor coupled to soft tissue and a surgical mesh configured to suspend tissue and/or organs. An adjuster is also provided and coupled to the anchor. Further, a wire is provided having one end coupled to the surgical mesh and the other end coupled to the adjuster where the wire is operable to suspend the surgical mesh at a desired suspension length. | 2011-04-14 |
20110087069 | System for remotely controlling two or more medical devices - A system for remotely controlling multiple medical devices. Included in the system are at least a first medical device and a second medical device, each of which are capable of performing one or more functions. Also included is a remote control unit having at least a first switch and a second switch. Connected to each of the medical devices is a controller that can simultaneously dispatch one or more device command signals to each of the medical devices in response to receiving one or more remote command signals from the remote control unit, thereby allowing a user to remotely and simultaneously control one or more functions associated with each of the medical devices. | 2011-04-14 |
20110087070 | SHEATHS FOR MEDICAL DEVICES - A device is disclosed for therapeutic and/or diagnostic use in or on a patient's body. The device can have a sheath and a tool. The sheath can be made, at least in part, from a laminate. The laminate can have reinforcement fibers in longitudinal, latitudinal, helical, and/or other configurations around the sheath. The tool can be at least partially within the sheath. The tool can be attached to the sheath at one or more lengths along the tool. The sheath can be removed from the tool and replaced. | 2011-04-14 |
20110087071 | ARTICULATION SHEATH FOR FLEXIBLE INSTRUMENTS - A sheath useful for remote steering, guidance and/or manipulation of a flexible instrument, including e.g. an endoscope, received through the sheath. | 2011-04-14 |
20110087072 | FLOW GUIDE - A flow guide directs a fluid flow across a surface of a device, for example a lens surface of an endoscope, in a controlled manner to facilitate flow attachment to the surface. Embodiments include features that impart a non-uniform velocity profile and/or include guide surfaces for facilitating flow attachment and/or coverage. | 2011-04-14 |
20110087073 | MEDICAL INSPECTION DEVICE - An improved medical inspection device at least comprises a hand-held portion, a display portion being connected with the hand-held portion and comprising a first printing circuit board, an image display module, an annular protuberance and at least one electrode contact, an inspection module comprising a joint portion, an inspection portion and a third printing circuit board, wherein the joint portion has a second printing circuit board provided at an inner surface thereof, and the inspection portion further comprises a lens, an image sensing unit and a light source, and a fastening ring that is detachably fastened with the annular protuberance of the display portion so as to firmly fasten the joint portion of the inspection module to the display portion. | 2011-04-14 |
20110087074 | Surgical retractor system - A surgical retractor system includes a first retractor and a second retractor. The first retractor comprises a first working channel for receiving a tool therethrough. The second retractor is capable of being advanced through the first working channel, and its proximal end is positioned in the vicinity of the distal end of the first retractor. The second retractor includes a second working channel for receiving a tool therethrough. In another aspect, a method for accessing a surgical site comprises inserting a first retractor into a first tissue, advancing a second retractor through a first working channel in the first retractor, and inserting the second retractor into a second tissue to retract the second tissue, with the distal end of the first retractor remaining in the vicinity of the proximal end of the second retractor sufficiently to allow access to the target tissue by a surgical tool. A tool for operating a second retractor located distally in a first retractor is described. The use of the system for surgery of the spine is described. | 2011-04-14 |
20110087075 | Anoscope - An insertion device for use during surgical procedure to enlarge an opening in a patient's tissue to facilitate access to an internal treatment site with a surgical instrument. The insertion device includes an anoscope including a flange, and an elongate body having proximal and distal ends extending distally from the flange along a longitudinal axis. The anoscope may include a configuration that is asymmetrical about a plane extending along the longitudinal axis that bisects the flange. | 2011-04-14 |
20110087076 | FEEDBACK SYSTEMS AND METHODS FOR COMMUNICATING DIAGNOSTIC AND/OR TREATMENT SIGNALS TO ENHANCE OBESITY TREATMENTS - Feedback systems and methods communicate implanted sensor-based feedback signals to promote behavior modifications that ameliorate obesity and other eating disorders. The system and methods described may also be applicable to any treatment in which presenting feedback regarding patients' eating and exercise habits is desired. The present invention provides a method and system for treating a patient by collecting ingestion and exercise information about the patient from an implanted sensor and communicating the collected information to the patient, his or her physician and/or other health care providers. In some embodiments, stimulation of the patient's stomach is also provided to reduce caloric intake. In some embodiments, the collected data is transmitted to a central server. Further embodiments may provide access to additional information in conjunction with the collected patient information, such as a calorie database, an exercise planner, and so forth, with the data optionally being used within a social networking system. | 2011-04-14 |
20110087077 | SYSTEM AND METHOD OF PROVIDING PATIENTS COST SAVING INCENTIVES FOR HEALTHY BEHAVIORS - Methods for monitoring a patient's health are provided. The methods compromise the steps of providing a website accessible via a computer for monitoring a patient's health; entering the patient's clinical data onto the website; analyzing the data to assign at least one preventive care protocol to the patient; providing a clinic for monitoring the progress of the patient's health; and providing the patient at least one incentive should the patient's health improve. | 2011-04-14 |
20110087078 | DEVICE FOR MEASURING INFANT FEEDING PERFORMANCE - Devices, systems and methods for measuring infant feeding performance. The device includes a body portion, a pressure sensor and an integrated circuit. The body portion includes a first end for receiving a fluid, a second end mateable with a feeding nipple, and a conduit In fluid communication with the first and second ends. The pressure sensor is disposed in the body portion, is in contact with the fluid in the conduit, and generates a signal representing a pressure of the fluid passing through the conduit during a feeding session. The integrated circuit is disposed in the body portion and is electrically connected to the pressure sensor. The integrated circuit receives the pressure signal and determines a feeding factor over the feeding session indicative of the infant feeding performance. | 2011-04-14 |
20110087079 | ACOUSTICAL PATIENT MONITORING USING A SOUND CLASSIFIER AND A MICROPHONE - When monitoring a patient, acoustic events (e.g., coughs, snores, impact sounds, verbalizations, etc.) relevant to the patient's status are detected by a microphone array ( | 2011-04-14 |
20110087080 | Detection Device For Vital Signs - The invention relates to a device ( | 2011-04-14 |
20110087081 | PERSONALIZED PHYSIOLOGICAL MONITOR - A personalized physiological monitor utilizes an individual genome sequence along with genetic and medical research databases so as to define a person's genetic predisposition to disease, drug reactions and environmental sensitivities so as to enhance the ability of the monitor to determine the physiological status of the person. | 2011-04-14 |
20110087082 | Method for Monitoring or Treating Nervous System Disorders - A medical device system for comparing a cardiopulmonary signal to a brain signal. In one embodiment of the invention, a medical device system is provided that includes a brain monitoring element, respiratory monitoring element and a processor. The processor is configured to receive a brain signal from the brain monitoring element and a respiratory signal from the respiratory monitoring element. The processor is further configured to compare the brain signal to the respiratory signal. Methods of comparing a brain signal to a cardiopulmonary signal are also provided. | 2011-04-14 |
20110087083 | ANALYTE MONITORING USING ONE OR MORE ACCELEROMETERS - The present disclosure relates to methods, devices, and systems for measuring a blood analyte, such as glucose. The disclosure relates more specifically to the use in such methods, devices, and systems of one or more accelerometers to aid in the collection of data, operation of the device, filtering, and other uses. In some embodiments, the accelerometers are three-dimensional accelerometers. An accelerometer can be used in conjunction with analyte monitoring that may be performed with infrared, near infrared, or other wavelength spectroscopy. The accelerometer may allow a monitoring instrument to expect noisy measurement data, indicate positioning of a measurement site for improved expected results, indicate position of the instrument, or help the user properly place or control the instrument. It may also improve analyte monitoring by providing motion information that can be used to help determine and reduce or remove movement-related signal artifacts or noise that may be present within the monitoring signal. | 2011-04-14 |
20110087084 | FACE MASK TYPE VITAL SIGNS MEASURING APPARATUS AND VITAL SIGNS MANAGEMENT SYSTEM USING THE SAME - There are provided a face mask type vital signs measuring apparatus and a vital signs management system using the same. The face mask type vital signs measuring apparatus according to an exemplary embodiment of the present invention may include: a detector detecting a vital sign; an analyzer analyzing the detected vital sign; a display displaying the analyzed vital sign; a transmitter transmitting the analyzed vital sign; and a face mask with the detector, the analyzer, the display, and the transmitter attached thereto. | 2011-04-14 |
20110087085 | METHOD AND DEVICE FOR INTRACOCHLEA IMPEDANCE MEASUREMENT - This method of determining an intracochlea tissue impedance comprises using at least two stimulating electrodes to apply an electrical stimulus to intracochlea tissue. A voltage caused by the stimulus is measured between two measuring electrodes distinct from the stimulating electrodes. From the voltage a stimulus-response characteristic of tissue between the two measuring electrodes is determined. This allows the tissue/electrode interface impedance and potential and the tissue impedance and potential to be uniquely determined. In turn, modiolus currents can be estimated in monopolar stimulation mode. Also provided is automated initiation of re-mapping of the device when tissue characteristics change | 2011-04-14 |
20110087086 | Method of Estimating Ocular Perfusion Pressure - A microprocessor-controlled tonometer measures both systole and diastole occurring in intraocular pressure so that this information can be used to estimate perfusion pressure. The microprocessor determines a ratio between ocular pulse amplitude and mean intraocular pressure, derives a multiplier from the ratio, multiplies the mean intraocular pressure by the multiplier to estimate mean central retinal artery pressure, and then estimates perfusion pressure by subtracting mean intraocular pressure from the estimate of central retinal artery pressure. | 2011-04-14 |
20110087087 | MR SPECTROSCOPY SYSTEM AND METHOD FOR DIAGNOSING PAINFUL AND NON-PAINFUL INTERVERTEBRAL DISCS - An MR Spectroscopy (MRS) system and approach is provided for diagnosing painful and non-painful discs in chronic, severe low back pain patients (DDD-MRS). A DDD-MRS pulse sequence generates and acquires DDD-MRS spectra within intervertebral disc nuclei for later signal processing & diagnostic analysis. An interfacing DDD-MRS signal processor receives output signals of the DDD-MRS spectra acquired and is configured to optimize signal-to-noise ratio (SNR) by an automated system that selectively conducts optimal channel selection, phase and frequency correction, and frame editing as appropriate for a given acquisition series. A diagnostic processor calculates a diagnostic value for the disc based upon a weighted factor set of criteria that uses MRS data extracted from the acquired and processed MRS spectra along regions associated with multiple chemicals that have been correlated to painful vs. non-painful discs. A diagnostic display provides a scaled, color coded legend and indication of results for each disc analyzed as an overlay onto a mid-sagittal T2-weighted MRI image of the lumbar spine for the patient being diagnosed. Clinical application of the embodiments provides a non-invasive, objective, pain-free, reliable approach for diagnosing painful vs. non-painful discs by simply extending and enhancing the utility of otherwise standard MRI exams of the lumbar spine. | 2011-04-14 |
20110087088 | COMPUTER-ASSISTED IDENTIFICATION AND TREATMENT OF AFFECTED ORGAN TISSUE - Computer-assisted processes are disclosed for using nuclear medicine image studies (e.g. PET or SPECT), preferably in combination with anatomic image studies (e.g., CT or MRI), to identify and quantify regions of affected organ tissue (e.g., myocardial infarcts), and to calculate doses of stem cells or other therapy to deliver to such regions. The resulting (static) image data showing the affected tissue may also be integrated with live (moving) image data, such as a fluoroscopy image, during a subsequent interventional procedure to generate a hybrid image showing the real time location of an injection catheter relative to the affected tissue. | 2011-04-14 |
20110087089 | MULTIPLE MODALITY COMPUTER AIDED DIAGNOSTIC SYSTEM AND METHOD - A diagnostic system having an image loader including a processor for processing multiple modality images, at least one of the multiple modality images being a mammogram image, the processing including generating diagnostic information based on a computer aided diagnostic tool and an image viewer simultaneously displaying the multiple modality images. | 2011-04-14 |
20110087090 | RADIATION THERAPY SYSTEM WITH REAL TIME MAGNETIC RESONANCE MONITORING - A radiation therapy system comprises: a radiation therapy subsystem ( | 2011-04-14 |
20110087091 | METHOD AND APPARATUS FOR COLLECTION OF CARDIAC GEOMETRY BASED ON OPTICAL OR MAGNETIC TRACKING - A cardiac imaging system including an imaging module including an ultrasound emitter and one or more position markers. A tracking and control system may include a position sensing system for sensing a location and orientation of the position marker relative to a predetermined reference. The tracking and control system may be operable with the imaging module to produce at least a three dimensional image of a patient's anatomy. A method of cardiac imaging may include operatively attaching one or more position markers to an imaging module including an ultrasound emitter. The method may further include sensing a location and orientation of the position marker relative to a predetermined reference, and producing at least a three dimensional image of a patient's anatomy by evaluating one or more images obtained by the imaging module and aligning the image(s) obtained by the imaging module relative to the location and orientation of the position marker. | 2011-04-14 |
20110087092 | Interchangeable Localizing Devices For Use With Tracking Systems - A system for tracking the position of an instrument relative to an area of interest includes a first fixator configured to carry first and second localizing devices. A second fixator is configured to carry the first localizing device. A third localizing device communicates with the first localizing device and the second localizing device communicates with the first localizing device such that the position of the second localizing device can be determined relative to the position of the third localizing device. The second localizing device is attachable to the instrument and the first localizing device is attachable to the first fixator such that the first localizing device communicates with the second localizing device on the instrument in order that the position of the second localizing device on the instrument can be determined relative to the third localizing device. | 2011-04-14 |
20110087093 | VALVE CONFIGURATIONS FOR IMPLANTABLE MEDICAL DEVICES - A medical device at least partially insertable into a patient. The device comprises a catheter portion comprising a flexible tube that is at least partially insertable into the patient, and a valve portion proximal to the catheter portion. The valve portion comprises a planar flexible member comprising first and second valve portions separated from one another by an internal slit. The thickness of the planar flexible member at the internal slit is less than the thickness of the planar flexible member at any other location. | 2011-04-14 |
20110087094 | ULTRASONIC DIAGNOSIS APPARATUS AND ULTRASONIC IMAGE PROCESSING APPARATUS - According to one embodiment, an ultrasonic diagnosis apparatus comprises a data acquisition unit configured to acquire a plurality of volume data over a predetermined period by executing ultrasonic scanning on a three-dimensional region including at least part of a heart of an object over the predetermined period, a detection condition setting unit configured to set detection conditions which are conditions used to detect a plurality of slices from the at least one volume data and include a detection accuracy associated with at least one slice and an angle defined between slices, a slice detection unit configured to detect the plurality of slices from the at least one volume data in accordance with the set detection conditions, an image generating unit configured to generate MPR images respectively corresponding to the plurality of detected slices, and a display unit configured to display the MPR images. | 2011-04-14 |
20110087095 | ULTRASOUND SYSTEM GENERATING AN IMAGE BASED ON BRIGHTNESS VALUE OF DATA - An ultrasound system that extracts label regions from ultrasound data based on image brightness. An ultrasound data acquisition unit forms ultrasound data of a target object. A processing unit is connected to the ultrasound data acquisition unit. The processing unit forms volume data including a plurality of voxels based on the ultrasound data, and extracts label regions having lower brightness values than a reference value from the volume data to thereby form an ultrasound image by rendering the extracted label regions. | 2011-04-14 |
20110087096 | METHOD AND SYSTEM FOR TISSUE RECOGNITION - A method for characterizing body tissue, comprising:
| 2011-04-14 |
20110087097 | METHOD AND SYSTEM FOR TISSUE IMAGING AND ANALYSIS - A method for detecting abnormal tissue in a region of healthy tissue, comprising:
| 2011-04-14 |
20110087098 | MAMMOGRAPHY SYSTEM AND METHOD FOR SONOGRAPHIC AND RADIOGRAPHIC EXAMINATION OF A BREAST - A mammography device for examining a breast has a support plate and a compression plate, between which the breast is positioned and compressed during a radiographic examination. An ultrasound transducer for obtaining a sonogram of the breast is brought into direct contact with the breast either by temporary mounting in one of the support plate or the compression plate or by exchanging one of the compression plate or the support plate with another plate that contains the ultrasound transducer. | 2011-04-14 |
20110087099 | NON-INVASIVE ULTRASONIC BODY CONTOURING - An apparatus for lysing adipose tissue, the apparatus comprising a power source and modulator assembly configured to supply modulated electrical power; an ultrasonic therapeutic transducer connected to said power source and modulator assembly and configured to convert the modulated electrical power to ultrasonic energy directed at a target volume in a region of a body containing adipose and non-adipose tissue, so as to selectively generally lyse the adipose tissue and generally not lyse the non-adipose tissue; an ultrasonic imaging sub-system configured to identify changes in the target volume resulting from the ultrasonic energy; and a lipolysis control computer configured to control said power source and modulator assembly based on the changes identified by said ultrasonic imaging sub-system. | 2011-04-14 |
20110087100 | METHOD AND DEVICE FOR UTERINE FIBROID TREATMENT - Methods and devices for both imaging and treating uterine fibroid tumors in one real-time system are provided. One minimally invasive method comprises introducing a sheath into a uterus and determining a location of a fibroid using a visualization element within or on the sheath. Upon identification, a portion of the sheath is steered to position at least one treatment needle at the determined location. The needle is then anchored in uterine tissue and the fibroid treated with the needle. | 2011-04-14 |
20110087101 | System and Method for Determining a Transfer Function - A system and method is provided for using ultrasound data backscattered from vascular tissue to estimate the transfer function of a catheter (including components attached thereto—e.g., IVUS console, transducer, etc.). Specifically, in accordance with a first embodiment of the present invention, a computing device is electrically connected to a catheter and used to acquire RF backscattered data from a vascular structure (e.g., a blood vessel, etc.). The backscattered ultrasound data is then used, together with an algorithm, to estimate the transfer function. The transfer function can then be used (at least in a preferred embodiment) to calculate response data for the vascular tissue (i.e., the tissue component of the backscattered ultrasound data). In a second embodiment of the present invention, an IVUS console is electrically connected to a catheter and a computing device and is used to acquire RF backscattered data from a vascular structure. The backscattered data is then transmitted to the computing device, where it is used to estimate the catheter's transfer function and to calculate response data for the vascular tissue. The response data and histology data are then used to characterize at least a portion of the vascular tissue (e.g., identify tissue type, etc.). | 2011-04-14 |